The Infectious Diseases Society of America is eyeing the Pandemic and All Hazards Preparedness Act (PAHPA), a must-pass piece of legislation that’s up for reauthorization this year, as a potential vehicle for passing a key antibiotic funding bill that failed to make it into the fiscal 2023 omnibus spending package. The bill, the Pioneering Antimicrobial Subscriptions to End Surging Resistance (PASTEUR) Act, would provide up-front payments to drug developers so they don’t have to wait for market demand to start...